- Cheong Wei Yang, deputy secretary (technology) of Singapore's Ministry of Health said pandemic preparedness relies on repurposing systems useful in the pandemic so that they can pivot back into a pandemic use when needed.
- Speakers include Setiaji, Expert adviser of healthtech to the minister and chief of digital transformation office, Ministry of Health, Indonesia; Akeem Ali, head of Asia-Pacific Centre for Environment and Health at World Health Organisation, Western Pacific Region; Kai-Fu Lee, Sinovation Ventures's chairman and chief executive; Jeremy Lim, Director at the National University of Singapore's Leadership Institute for Global Health Transformation.
SINGAPORE, Nov. 18, 2022 /PRNewswire/ -- Economist Impact's third annual Future of Healthcare Week brought together health ministers, doctors, investors, scientists and senior business representatives from health and technology. Live from Singapore and moderated by Economist Impact, a cohort of expert speakers examined the vulnerabilities and opportunities that the recent crisis catalysed to "build back better".
In a panel discussion on fostering value-based care, Jeremy Lim, Director at the National University of Singapore's Leadership Institute for Global Health Transformation said. "Doctors like to think that we are artists but...in value based healthcare, we should be technicians because as it said "variation is the enemy of quality". Jeremey continued by expressing his positive view towards the shift and adoption of patient-centric thinking, "Younger doctors, particularly, are much more ready to embrace evidence-based medicine and standardised approaches."
The second day of discussions focussed on the aftermath of covid-19. Cheong Wei Yang, deputy secretary (technology) of Singapore's Ministry of Health shared, "The way to ensure we are always prepared for the next pandemic is that the systems we have found very useful in the pandemic are repurposed into areas which are of ongoing concern...so [the system] can pivot back into a pandemic use as and when we need. "
On healthy ageing, Paulin Straughan, director of Centre for Research on Successful Ageing (ROSA) at Singapore Management University said, "Population ageing simply means that when we don't have that younger cohort and are going to have to depend on our older cohort". To leverage the benefits of the more experienced workforce, she said, "what employers need to do is learn how to create job responsibilities that match the talent and experience of the different layers of our labour force".
The third and final day of discussions, which took place online, examined the opportunities provided by AI in healthcare. Kai-Fu Lee, chairman and chief executive of Sinovation Ventures, and president of Sinovation Ventures Artificial Intelligence Institute said, "In the next 10 years, we really see huge opportunities in medical imaging and pathology, in drug discovery, in multi omics, diagnostic AI, in personalised treatment and in robotic surgery".
Future of Healthcare Week also provided macro-level analysis coupled with practical insights on healthcare-system weaknesses, labour shortages, green health, data application and ownership during the rise of Web 3.0. On-demand access is now available, along with event details, on the event website.
Chaired by The Economist Group's editors, Future of Healthcare Week featured a cohort of expert speakers, including:
- Alice Budisatrijo, head of misinformation policy, Asia-Pacific, Meta
- Akeem Ali, head, Asia-Pacific Centre for Environment and Health, World Health Organisation, Western Pacific Region
- Alexander Maxwell, vice-president, healthcare supply chain operations, DKSH
- Clair Deevy, global director of social impact, WhatsApp
- Deborah Seifert, Country manager, Thailand and Indochina, Pfizer Inc, and chairperson, Pfizer Emerging Markets Asia Regional Council on Diversity, Equity and Inclusion
- Jeremy Lim, director, Leadership Institute for Global Health Transformation, Saw Swee Hock School of Public Health, National University of Singapore
- Jiadi Yu, chief investment officer, International Finance Corporation
- Lee Chien Earn, deputy group chief executive (Regional Health System), Singapore Health Services (SingHealth)
- Manus Potaporn, deputy director-general, Department of Medical Services, Ministry of Public Health, Thailand
- Mary Wong-Hemrajani, chairman, Global Chinese Breast Cancer Organisations Alliance
- Peter Hotez, dean, National School of Tropical Medicine, Baylor College of Medicine
- Roberta Sarno, director of digital health, Asia Pacific Medical Technology Association (APACMed)
- Sania Nishtar, cardiologist and member of the Senate, Pakistan
- Surakameth Mahasirimongkol, director, Medical Life Sciences Institute, Department of Medical Sciences, Ministry of Public Health, Thailand
- and many more
Economist Impact's third annual Future of Healthcare Week Asia united 300 healthcare leaders in Singapore-joined by 1,000 organisations online-to examine the vulnerabilities and opportunities that the recent crisis has catalysed. Over 3 days, policymakers, healthcare providers, academics and scientists shared practical learnings with representatives from industry, patient associations, charities and finance.
To engage with Future of Healthcare Week on social media, use #EconFutureofHealthcare in your conversations and follow @EconomistEvents.
For further details and questions, and to register to watch on-demand, please contact:
Future of Healthcare Week is supported by Pfizer and Whatsapp. Insight hours are supported by Abbott, Hong Kong Trade Development Council, ASGH and Philips.
PR Newswire is the communication partner of Future of Healthcare Week.
About Economist Impact
Economist Impact empowers businesses, governments and foundations to catalyse change and enable progress. Uniting the expertise The Economist Group is known for under a single brand, Economist Impact brings together policy research and insights, data visualisation, custom storytelling, events and media.
Economist Impact combines the rigour of a think tank with the creativity of a media brand, engaging an influential audience in the areas of sustainability, healthcare and new globalisation. View our global events.
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com. In addition, to learn more, please visit us on www.Pfizer.com and follow us on Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.
More than 2 billion people in over 180 countries use WhatsApp to stay in touch with friends and family, anytime and anywhere.
WhatsApp started as an alternative to SMS. Our product now supports sending and receiving a variety of media: text, photos, videos, documents, and location, as well as voice calls. Some of your most personal moments are shared with WhatsApp, which is why we built end-to-end encryption into our app. Behind every product decision is our desire to let people communicate anywhere in the world without barriers.
For more information, visit www.whatsapp.com.